Altra Reports First-Quarter 2020 Results and Provides Business Update
Q1 Financial Performance Reflects Moderate COVID-19 ImpactSwift Actions Taken on Employee Safety, Supply Chain Security and Business Continuity Reports strong operating […]
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response
– First Quarter TIBSOVO® Net Revenue of $22.7 Million; Company Reiterates 2020 TIBSOVO® Net U.S. Revenue Guidance of $105–115 Million –– […]
Phase 2/3 Randomized Controlled Trial of Remestemcel-L in 300 Patients With COVID-19 Acute Respiratory Distress Syndrome Begins Enrollment
NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, […]
Plug Power Customer ARYZTA Highlights Substantial Productivity Increases Through Use of GenDrive Hydrogen Fuel Cells
LATHAM, N.Y., April 30, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), the leading company building the clean hydrogen […]
ConnectOne Bancorp, Inc. Reports First Quarter 2020 Results
ENGLEWOOD CLIFFS, N.J., April 30, 2020 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company […]
Altra Industrial Motion Corp. Announces Second Quarter 2020 Dividend
BRAINTREE, Mass., April 30, 2020 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC), a leading global manufacturer and supplier […]
Allegiance Bancshares, Inc. Reports First Quarter 2020 Results
Promptly supported customers, employees and community with proactive response to the COVID-19 pandemicApproved more than 3,500 loans in excess of […]
ORBCOMM Announces First Quarter 2020 Results
– Total Revenues of $66.2 Million, In Line with Guidance –– Service and Product Gross Margins Increase Over Last Year –– […]
Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies
NEW YORK and SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update
– FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust Clinical […]
